#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1032227	B	Inhibition of CDC2L1 at 3 uM		1	ALA1142492	single protein format	Scientific Literature
2.	ALA1060184	B	Binding constant for CDC2L1 kinase domain	Homo sapiens	38	ALA1150977	single protein format	Scientific Literature
3.	ALA1052881	B	Inhibition of CDC2L1 assessed as enzyme activity at 1 uM relative to untreated control		1	ALA1155237	single protein format	Scientific Literature
4.	ALA1168817	B	Inhibition of CDC2L1 at 1 uM		6	ALA1165965	single protein format	Scientific Literature
5.	ALA1174100	B	Inhibition of CDC2L1 at 10 uM		2	ALA1177794	single protein format	Scientific Literature
6.	ALA1244755	B	Binding affinity to CDC2L1		7	ALA1240346	single protein format	Scientific Literature
7.	ALA1827288	B	Activity of CDC2L1 kinase at 1 uM		1	ALA1821651	single protein format	Scientific Literature
8.	ALA1908405	B	Binding constant for CDC2L1 kinase domain		72	ALA1908390	single protein format	Scientific Literature
9.	ALA2209340	B	Inhibition of CDC2L1 assessed as residual activity at 10 uM relative to control		1	ALA2203081	single protein format	Scientific Literature
10.	ALA2422449	B	Inhibition of CDK11 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	Homo sapiens	12	ALA2417377	single protein format	Scientific Literature
11.	ALA2428176	B	Competitive binding affinity to CDK11 (unknown origin) at 10 uM in presence of ATP relative to control	Homo sapiens	3	ALA2424622	single protein format	Scientific Literature
12.	ALA2428178	B	Competitive binding affinity to CDC2L1 (unknown origin) at 10 uM in presence of ATP relative to control	Homo sapiens	4	ALA2424622	single protein format	Scientific Literature
13.	ALA2429327	B	Binding affinity to CDC2L1 (unknown origin)	Homo sapiens	1	ALA2424622	single protein format	Scientific Literature
14.	ALA2439141	B	Inhibition of human wild type CDK11 at 1 uM by qPCR analysis relative to control	Homo sapiens	1	ALA2434948	single protein format	Scientific Literature
15.	ALA3112119	B	Inhibition of CDC2L1 (unknown origin) assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	Homo sapiens	1	ALA3108735	single protein format	Scientific Literature
16.	ALA3630639	B	Inhibition of CDK11 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	Homo sapiens	1	ALA3627674	single protein format	Scientific Literature
17.	ALA3707511	B	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	Homo sapiens	1	ALA3639044	single protein format	BindingDB Database
18.	ALA3773959	B	Inhibition of human recombinant CDK11 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	Homo sapiens	1	ALA3769377	single protein format	Scientific Literature
19.	ALA3812231	B	Inhibition of human CDK11 (1 to 360 amino acid residues) assessed as enzyme activity at 10 uM by KINOMEScan assay expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	Homo sapiens	1	ALA3808372	assay format	Scientific Literature
20.	ALA3887935	B	Competitive Binding Assay (KINOMEscan): For the competitive binding assay, test compounds were screened at 10 uM against 70 diverse kinase targets for competitive binding using the KINOMEscan technology (Ambit Biosciences) (Karaman, et al. (2008) Nature biotechnology 26:127-132). 11-point Kd curves were determined for hits identified during the initial screen.	Homo sapiens	1	ALA3886510	single protein format	BindingDB Database